5610

    506820

    ASTRAZEN

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ASTRAZENECA PHARMA IND LT Share Price Today

    ASTRAZENECA PHARMA IND LT is currently trading at ₹8139, down by ₹65.0 from the previous close. The stock touched an intraday high of ₹8254.00 and a low of ₹8114.50 during the latest trading session. Over the past one year, ASTRAZENECA PHARMA IND LT has delivered a loss of 10.34%, while the stock has declined 1.67% in the last one month.

    ASTRAZENECA PHARMA IND LT performance

    Today’s low Today’s high
    ₹ 8114.50 ₹ 8254.00
    ₹ 8204.00
    52 week low 52 week high
    ₹ 7551.50 ₹ 9849.50
    ₹ 8204.00
    Open Price ₹ 8204.00
    Prev. Close ₹ 8204.00
    Volume (Shares) 6.00
    Total traded value ₹ .49
    Upper Circuit ₹ 9844.50
    Lower Circuit ₹ 6563.50
    info

    Investment Returns

    Over 1 Month -1.67% Over 3 Months 5.29% Over 6 Months -3.07% Over 1 Year -10.34%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ASTRAZENECA PHARMA IND LT fundamentals


    • Market cap (Cr) 20,510.00
    • P/E Ratio (TTM) 109.32
    • Beta 0.47
    • Book Value / share 349.11
    • Return on equity 23.63%
    • EPS (TTM) 76.57
    • Dividend yield 0.44%
    • Net profit/quarter (Cr) 44.88
    info icon alternate text
    • Market cap (Cr) 20,500.10
    • P/E Ratio (TTM) 109.32
    • Beta 0.43
    • Book Value / share 349.11
    • Return on equity 23.63%
    • EPS (TTM) 76.57
    • Dividend yield 0.44%
    • Net profit/quarter (Cr) 44.88
    info icon alternate text

    ASTRAZENECA PHARMA IND LT Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 578.61
    Operating Expense 525.33
    Net Profit 44.88
    Net Profit Margin (%) 7.75
    Earnings Per Share (EPS) 17.95
    EBITDA 65.78
    Effective Tax Rate (%) 22.80
    Particulars DEC 2025 (Values in Cr)
    Revenue 611.57
    Operating Expense 571.64
    Net Profit 32.59
    Net Profit Margin (%) 5.32
    Earnings Per Share (EPS) 13.04
    EBITDA 51.44
    Effective Tax Rate (%) 29.97
    Particulars SEP 2025 (Values in Cr)
    Revenue 559.09
    Operating Expense 487.15
    Net Profit 54.22
    Net Profit Margin (%) 9.69
    Earnings Per Share (EPS) 21.69
    EBITDA 76.05
    Effective Tax Rate (%) 25.54
    Particulars JUN 2025 (Values in Cr)
    Revenue 526.31
    Operating Expense 462.49
    Net Profit 55.83
    Net Profit Margin (%) 10.60
    Earnings Per Share (EPS) 22.33
    EBITDA 91.99
    Effective Tax Rate (%) 25.26
    Particulars MAR 2025 (Values in Cr)
    Revenue 480.48
    Operating Expense 412.48
    Net Profit 58.25
    Net Profit Margin (%) 12.12
    Earnings Per Share (EPS) 23.30
    EBITDA 96.84
    Effective Tax Rate (%) 25.76
    Particulars MAR 2026 (Values in Cr)
    Revenue 2275.58
    Operating Expense 2046.62
    Net Profit 187.52
    Net Profit Margin (%) 8.24
    Earnings Per Share (EPS) 75.01
    EBITDA 285.27
    Effective Tax Rate (%) 25.64
    Particulars MAR 2025 (Values in Cr)
    Revenue 1716.29
    Operating Expense 1503.77
    Net Profit 115.74
    Net Profit Margin (%) 6.74
    Earnings Per Share (EPS) 46.30
    EBITDA 197.81
    Effective Tax Rate (%) 25.97
    Particulars MAR 2024 (Values in Cr)
    Revenue 1295.53
    Operating Expense 1127.22
    Net Profit 161.51
    Net Profit Margin (%) 12.46
    Earnings Per Share (EPS) 64.60
    EBITDA 235.67
    Effective Tax Rate (%) 26.43
    Particulars MAR 2023 (Values in Cr)
    Revenue 1002.97
    Operating Expense 854.74
    Net Profit 99.29
    Net Profit Margin (%) 9.89
    Earnings Per Share (EPS) 39.72
    EBITDA 150.98
    Effective Tax Rate (%) 25.95
    Particulars MAR 2022 (Values in Cr)
    Revenue 805.60
    Operating Expense 737.32
    Net Profit 61.59
    Net Profit Margin (%) 7.64
    Earnings Per Share (EPS) 24.64
    EBITDA 100.94
    Effective Tax Rate (%) 25.81
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 308.14
    ROE % 23.63
    ROCE % 32.94
    Total Debt to Total Equity 0.03
    EBITDA Margin 17.15
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 284.77
    ROE % 24.84
    ROCE % 33.26
    Total Debt to Total Equity 0.01
    EBITDA Margin 18.19
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 235.48
    ROE % 22.95
    ROCE % 30.47
    Total Debt to Total Equity 0.01
    EBITDA Margin 18.82
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 204.56
    ROE % 12.73
    ROCE % 16.76
    Total Debt to Total Equity 0.02
    EBITDA Margin 12.53
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 182.47
    ROE % 22.74
    ROCE % 29.94
    Total Debt to Total Equity 0.03
    EBITDA Margin 18.23
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 536.70
    Total Assets 1518.12
    Total Liabilities 1518.12
    Total Equity 770.35
    Share Outstanding 2
    Price to Book Ratio 27.93
    Return on Assets (%) 7.62
    Return on Capital (%) 15.02
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 505.84
    Total Assets 1078.03
    Total Liabilities 1078.03
    Total Equity 711.92
    Share Outstanding 2
    Price to Book Ratio 18.68
    Return on Assets (%) 14.98
    Return on Capital (%) 22.69
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 500.48
    Total Assets 984.87
    Total Liabilities 984.87
    Total Equity 588.69
    Share Outstanding 2
    Price to Book Ratio 13.79
    Return on Assets (%) 10.08
    Return on Capital (%) 16.87
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 448.46
    Total Assets 856.56
    Total Liabilities 856.56
    Total Equity 511.39
    Share Outstanding 2
    Price to Book Ratio 12.49
    Return on Assets (%) 7.19
    Return on Capital (%) 12.05
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 352.35
    Total Assets 774.71
    Total Liabilities 774.71
    Total Equity 456.17
    Share Outstanding 2
    Price to Book Ratio 16.50
    Return on Assets (%) 12.04
    Return on Capital (%) 20.45
    Particulars MAR 2025 (Values in Cr)
    Net Income 156.36
    Cash from Operations 129.55
    Cash from Investing 30.80
    Cash from Financing -65.59
    Net change in Cash 30.57
    Free Cash Flow 131.30
    Particulars MAR 2024 (Values in Cr)
    Net Income 219.54
    Cash from Operations 84.30
    Cash from Investing 21.74
    Cash from Financing -44.38
    Net change in Cash 5.23
    Free Cash Flow 95.06
    Particulars MAR 2023 (Values in Cr)
    Net Income 134.10
    Cash from Operations 99.11
    Cash from Investing 18.11
    Cash from Financing -24.48
    Net change in Cash 51.92
    Free Cash Flow 107.63
    Particulars MAR 2022 (Values in Cr)
    Net Income 83.04
    Cash from Operations 125.59
    Cash from Investing 4.74
    Cash from Financing -9.46
    Net change in Cash 96.08
    Free Cash Flow 135.21
    Particulars MAR 2021 (Values in Cr)
    Net Income 127.09
    Cash from Operations 137.34
    Cash from Investing 173.03
    Cash from Financing -8.97
    Net change in Cash 268.84
    Free Cash Flow 145.05
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.03 13.24 1.55 245.46 23.12 38.85
    BLISS GVS PHARMA LTD 511.55 41.12 4.54 5425.31 118.35 552.90
    CIPLA LTD. 1452.35 30.82 3.40 117327.41 1165.55 1672.20
    FERMENTA BIOTECH LTD. 369.50 16.30 2.67 1087.47 256.40 401.20
    GLAXOSMITHKLINE PHARMA LT 2402.90 42.30 17.95 40706.58 2088.00 3356.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.03 22.40 4.12 245.46 23.12 38.85
    AMRUTAJAN HEALTH LTD 538.95 24.16 4.20 1558.14 490.00 789.95
    BLISS GVS PHARMA LTD 511.55 55.30 4.69 5425.31 118.35 552.90
    ABBOTT INDIA LTD. 26712.05 36.57 11.88 56763.11 25164.00 35280.00

    ASTRAZENECA PHARMA IND LT shareholding pattern

    Holding
    16.42%
    75.0%
    2.78%
    5.79%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    ASTRAZENECA PHARMA IND LT Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    8204.00 0.00 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 8240.40
    • 26 Days 8368.00
    • 10 Days 8279.80
    • 50 Days 8415.30
    • 12 Days 8295.20
    • 100 Days 8490.10
    • 20 Days 8344.30
    • 200 Days 8527.90
    8236.50 PIVOT
    First Support 8129.00 First Resistance 8311.50 Second Support 8054.00 Second Resistance 8419.00 Third Support 7946.50 Third Resistance 8494.00
    RSI 43.30 ADX 21.70 MACD -72.79 Williams % R -71.38 Commodity Channel Index (CCI) -73.19
    Date 2026-07-07 Week 2273.00 Same Day 1911.00 Month 3641.00
    1 Year 0.47 3 Year 0.53
    Over 1 Month
    -1.67% down
    Over 1 Year
    -10.34% down
    Over 3 Months
    5.29% down
    Over 3 Years
    29.83% down
    Over 6 Months
    -3.07% down
    Over 5 Years
    17.83% down

    ASTRAZENECA PHARMA IND LT Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    18 Jul 2025 32.0 Final 18 Jul 2025 Equity shares
    05 Jul 2024 24.0 Final 05 Jul 2024 Equity shares
    14 Jul 2023 16.0 Final 14 Jul 2023 Equity shares
    07 Jul 2022 8.0 Final 08 Jul 2022 Equity shares
    18 Aug 2021 2.0 Interim 20 Aug 2021 Equity shares
    20 Aug 2020 2.0 Interim 21 Aug 2020 Equity shares
    20 Aug 2019 1.0 Interim 21 Aug 2019 Equity shares
    09 Jul 2012 3.5 Final 11 Jul 2012 Equity shares
    07 Jul 2011 10.0 Final 09 Jul 2011 Equity shares
    06 May 2010 10.0 Final 08 May 2010 Equity shares
    30 Apr 2009 15.0 Final 05 May 2009 Equity shares
    11 Apr 2008 15.0 Final 16 Apr 2008 Equity shares
    22 Mar 2007 12.0 Interim 24 Mar 2007 Equity shares
    12 Apr 2006 0.0 Final 14 Apr 2006 Equity shares
    Ex-Date Ex-Bonus Ratio
    19 Nov 1995 13 Nov 1995 1:1
    Ex-Date Old FV NEW FV Record Date
    15 Jun 2006 10.0 2.0 22 Jun 2006
    Dividend date Dividend amount Dividend type Record date Instrument type
    18 Jul 2025 32.0 Final 18 Jul 2025 Equity shares
    05 Jul 2024 24.0 Final 05 Jul 2024 Equity shares
    14 Jul 2023 16.0 Final 14 Jul 2023 Equity shares
    07 Jul 2022 8.0 Final 08 Jul 2022 Equity shares
    18 Aug 2021 2.0 Interim 20 Aug 2021 Equity shares
    20 Aug 2020 2.0 Interim 21 Aug 2020 Equity shares
    20 Aug 2019 1.0 Interim 21 Aug 2019 Equity shares
    09 Jul 2012 3.5 Final 11 Jul 2012 Equity shares
    07 Jul 2011 10.0 Final 09 Jul 2011 Equity shares
    06 May 2010 10.0 Final 08 May 2010 Equity shares
    30 Apr 2009 15.0 Final 05 May 2009 Equity shares
    11 Apr 2008 15.0 Final 16 Apr 2008 Equity shares
    22 Mar 2007 12.0 Interim 24 Mar 2007 Equity shares
    12 Apr 2006 0.0 Final 14 Apr 2006 Equity shares
    Ex-Date Ex-Bonus Ratio
    19 Nov 1995 13 Nov 1995 1:1
    Ex-Date Old FV NEW FV Record Date
    15 Jun 2006 10.0 2.0 22 Jun 2006

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Astrazeneca Pharma India Ltd?

    Answer Field

    Astrazeneca Pharma India Ltd share price is for NSE ₹ 8,139.00 & for BSE ₹ 8,125.00 as on Jul 08 2026 03:15 PM.

    What is the Market Cap of Astrazeneca Pharma India Ltd Share?

    Answer Field

    The market cap of Astrazeneca Pharma India Ltd for NSE ₹ 20,510.00 & for BSE ₹ 0.00 as on Jul 08 2026 03:15 PM.

    What is the 52 Week High and Low of Astrazeneca Pharma India Ltd?

    Answer Field

    The 52 Week High and Low of Astrazeneca Pharma India Ltd for NSE is ₹ 9,849.50 and ₹ 7,551.50 and for BSE is ₹ 9,850.00 and ₹ 7,630.00.

    What is 1 year return for Astrazeneca Pharma India Ltd?

    Answer Field

    The 1 year returns on the stock has been -10.34%.

    What is the P/E Ratio of Astrazeneca Pharma India Ltd Share?

    Answer Field

    As on Jul 08 2026 03:15 PM the price-to-earnings (PE) ratio for Astrazeneca Pharma India Ltd share is 109.32.

    What is the PB ratio of Astrazeneca Pharma India Ltd Share?

    Answer Field

    As on Jul 08 2026 03:15 PM, the price-to-book (PB) ratio for Astrazeneca Pharma India Ltd share is 349.11.

    How to Buy Astrazeneca Pharma India Ltd Share?

    Answer Field

    You can trade in Astrazeneca Pharma India Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Astrazeneca Pharma India Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Astrazeneca Pharma India Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Astrazeneca Pharma India Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |